Business
Expansion of Chronic Kidney Disease Advisory Board
Expansion of Chronic Kidney Disease Advisory Board.
About this update from Renalytix Plc
[{"type":"text","content":"\n \nRNS Number : 9746H Renalytix AI PLC 06 August 2019 \n\n6 August 2019\n \n \nRenalytix AI plc\n(\"RenalytixAI\" or the \"Company\")\n \nExpansion of Chronic Kidney Disease Advisory Board\n \nIntended appointment of an additional Non-Executive Director\n \nRenalytix AI plc (AIM: RENX), a developer of artificial intelligence clinical in vitro diagnostics for kidney disease, announces the expansion of its core investigator group for lead product KidneyIntelX ™ for earlier identification of fast-progressing kidney disease in Type 2 diabetes.\n \nThe new advisory members are: \n \n§ Jonathan Himmelfarb, MD, Professor Division of Nephrology University of Washington, Director Kidney Research Institute, Director, Center for Dialysis Innovation, Director Kidney Precision Medicine Project\nhttps://nephrology.uw.edu/faculty/jonathan-himmelfarb-md \n \n§ Joseph Vassalotti, MD, FASN, Chief Medical Officer, National Kidney Foundation, Associate Clinical Professor of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai\nhttps://www.kidney.org/about/board \n \n§ George Bakris, MD, Professor of Medicine, University of Chicago, Director, Comprehensive Hypertension Center, Member Board of Directors National Kidney Foundation\nhttps://www.uchicagomedicine.org/find-a-physician/physician/george-bakris \n \nThe Company intends to continue to build a diverse group of leading clinical and research advisors and investigators into its clinical trial, regulatory, reimbursement and commercial adoption programmes for KidneyIntelX™. The Company believes expert opinion is critical to ensuring quality product development processes that adequately address unmet clinical need in chronic kidney disease and ensure optimal impact on improved patient outcomes and health economics. \n \nThe existing members of the RenalytixAI Chronic Kidney Disease Advisory Board are as follows:\n \n· Chirag Parikh (Chair), Director, Division of Nephrology, Ronald Peterson Professor of Medicine, Johns Hopkins School of Medicine\n· Sue Quaggin, MD, Director Feinberg Cardiovascular and Renal Research Institute, Chief of Nephrology and Hypertension, Department of Medicine Northwestern University\n· John Qua...